Loading icon
Press enter or spacebar to select a desired language.
Research
Press enter or spacebar to select a desired language.

PubMed COVID-19 Clinical Care

2811 - 2820 of 3460 results found

Post-exposure prophylaxis with SA58 (anti-SARS-COV-2 monoclonal antibody) Nasal Spray for the prevention of symptomatic COVID-19 in healthy adult workers: a randomized, single-blind, placebo-controlled clinical study

Date
Tuesday, May 09, 2023 - 4:00 AM
Description
Monoclonal antibodies (mAbs) and the post-exposure prophylaxis (PEP) with mAbs represent a very important public health strategy against coronavirus disease 2019 (COVID-19). This study has assessed a new Anti-SARS-COV-2 mAb (SA58) Nasal Spray for PEP

Profile analysis of emerging respiratory virus in children

Date
Tuesday, May 09, 2023 - 4:00 AM
Description
Acute respiratory infections (ARIs) are caused by a variety of microorganisms. Of all ARIs, 80% are caused by viruses such as human respiratory syncytial virus, metapneumovirus, influenza, parainfluenza, rhinovirus, and, more recently, Sars-CoV-2

Post-pandemic tourism strategies: A case of Himachal Pradesh

Date
Monday, May 08, 2023 - 4:00 AM
Description
Tourism has always been a vulnerable industry. Minimal disturbances can halt or even destroy tourism and its associated economy. There is no dearth of research on vulnerability and resilience of the tourism industry for various tourism destinations